Kimberly A Noonan

This inventor holds 7 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimberly A Noonan. Retrieved from https://idiyas.com/inventor/kimberly-a-noonan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 17)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 1 (Patent Applications = 10)

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 33(Granted Patents)

Company Filing History:

7 out of 3,801

Johns Hopkins University

patents

Years Active: 2016-2022

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11478548 - Marrow infiltrating lymphocytes (MILs) as a source of T-cells for chimeric antigen receptor (CAR) therapy (2022-10-25),

2. 11406666 - Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions (2022-08-09),

3. 11160830 - Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions (2021-11-02),

4. 10406178 - Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions (2019-09-10),

5. 10172887 - Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions (2019-01-08),

6. 9687510 - Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions (2017-06-27),

7. 9468643 - PDE5 inhibitor compositions and methods for immunotherapy (2016-10-18),

Title: The Innovative Contributions of Kimberly A. Noonan

Introduction

Kimberly A. Noonan is a prominent inventor based in Baltimore, MD, known for her significant contributions to the field of medical research and therapy. With a total of seven patents to her name, she has made remarkable strides in the development of innovative treatments, particularly in cancer therapy.

Latest Patents

Among her latest patents is the invention titled "Marrow infiltrating lymphocytes (MILs) as a source of T-cells for chimeric antigen receptor (CAR) therapy." This patent outlines a method for creating recombinant MILs by obtaining bone marrow containing these lymphocytes and transfecting them with a nucleic acid that encodes a chimeric antigen receptor. Another notable patent is "Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions," which describes methods for activating MILs in low-oxygen environments and their application in cancer treatment.

Career Highlights

Kimberly A. Noonan is affiliated with The Johns Hopkins University, where she conducts her research and develops her innovative therapies. Her work has been instrumental in advancing the understanding and treatment of various medical conditions, particularly in oncology.

Collaborations

Throughout her career, Noonan has collaborated with esteemed colleagues such as Ivan M. Borrello and Drew M. Pardoll. These partnerships have further enhanced her research and contributed to the success of her innovative projects.

Conclusion

Kimberly A. Noonan's contributions to medical research and her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in cancer therapy and other medical treatments.

Profile summary based on public USPTO records.